Matinas BioPharma Holdings, Inc.
MTNB · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,482 | $46,973 | $108,406 | $212,280 |
| - Cash | $7,284 | $4,787 | $6,830 | $21,030 |
| + Debt | $2,894 | $3,556 | $4,124 | $4,703 |
| Enterprise Value | -$1,908 | $45,742 | $105,700 | $195,953 |
| Revenue | $0 | $1,096 | $3,188 | $33 |
| % Growth | -100% | -65.6% | 9,560.6% | – |
| Gross Profit | $0 | $1,096 | -$13,490 | -$14,550 |
| % Margin | – | 100% | -423.1% | -44,090.9% |
| EBITDA | -$19,190 | -$22,825 | -$24,234 | -$24,455 |
| % Margin | – | -2,082.6% | -760.2% | -74,106.1% |
| Net Income | -$24,251 | -$22,942 | -$20,997 | -$23,283 |
| % Margin | – | -2,093.2% | -658.6% | -70,554.5% |
| EPS Diluted | -4.98 | -5.28 | -3 | -5.04 |
| % Growth | 5.7% | -76% | 40.5% | – |
| Operating Cash Flow | -$15,885 | -$15,278 | -$19,156 | -$15,223 |
| Capital Expenditures | $0 | -$218 | -$892 | -$260 |
| Free Cash Flow | -$15,885 | -$15,496 | -$20,048 | -$15,483 |